This inventor holds 2 USPTO granted patents. Top assignees: The UAB Research Foundation (The University of Alabama at Birmingham), The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2000-2006.
Company Filing History:
2 out of 641 
1 out of 1,217 
1 out of 3,693 
Years Active: 2000-2006
Title: The Innovative Contributions of Stuart Knechtle
Introduction
Stuart Knechtle is a notable inventor based in Oregon, Wisconsin, who has made significant contributions to the field of immunology. His work primarily focuses on methods of inducing immune tolerance, which have important implications for treating immune system disorders.
Latest Patents
Knechtle holds 2 patents related to his innovative methods. His latest patents include techniques for treating immune system disorders that do not involve T cell proliferation. One of his methods involves administering an immunotoxin that comprises a mutant diphtheria toxin moiety linked to an antibody moiety, which routes by the anti-CD3 pathway. This method can effectively treat graft-versus-host disease. Additionally, he has developed a method to inhibit rejection responses by inducing immune tolerance in recipients of foreign mammalian donor tissue or cells. This involves reducing the recipient's peripheral blood T-cell lymphocyte population by at least 80% before transplanting donor cells, thereby inhibiting the rejection response.
Career Highlights
Throughout his career, Knechtle has worked with esteemed organizations, including the UAB Research Foundation and the United States of America as represented by the Department of Health. His innovative approaches have garnered attention in the scientific community.
Collaborations
Knechtle has collaborated with notable colleagues such as David M. Neville and Judith M. Thomas, contributing to the advancement of research in immunology.
Conclusion
Stuart Knechtle's work in immunology and his innovative patents highlight his significant contributions to the field. His methods for inducing immune tolerance represent a promising avenue for treating immune system disorders.